147 related articles for article (PubMed ID: 10887279)
1. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
O'Brien BJ; Yee R
Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
[No Abstract] [Full Text] [Related]
2. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
3. Implantable cardioverter/defibrillator therapy: the meaning of terms.
Smith ER
Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
[No Abstract] [Full Text] [Related]
4. Chapter 3. Cost effectiveness of ICD therapy: a review of published evidence.
O'Brien BJ
Can J Cardiol; 2000 Oct; 16(10):1307-12. PubMed ID: 11064306
[No Abstract] [Full Text] [Related]
5. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the implantable cardioverter defibrillator?
Hlatky MA; Bigger T
Lancet; 2001 Jun; 357(9271):1817-8. PubMed ID: 11410185
[No Abstract] [Full Text] [Related]
7. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.
Sheldon R; O'Brien BJ; Blackhouse G; Goeree R; Mitchell B; Klein G; Roberts RS; Gent M; Connolly SJ
Circulation; 2001 Oct; 104(14):1622-6. PubMed ID: 11581139
[TBL] [Abstract][Full Text] [Related]
8. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillators--for whom?
Connolly SJ
Lancet; 1998 Aug; 352(9125):338-40. PubMed ID: 9717916
[No Abstract] [Full Text] [Related]
10. The utilization of the implantable defibrillator--a European enigma.
Camm AJ; Nisam S
Eur Heart J; 2000 Dec; 21(24):1998-2004. PubMed ID: 11102250
[No Abstract] [Full Text] [Related]
11. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of implantable cardioverter-defibrillators.
Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
[No Abstract] [Full Text] [Related]
13. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
14. Alternative heart therapy: Defibrillator is less invasive, called cost-effective.
Lee J
Mod Healthc; 2012 Oct; 42(44):12-3. PubMed ID: 23227668
[No Abstract] [Full Text] [Related]
15. The implantable cardioverter-defibrillator. Current indications and controversies.
Raj SR; Sheldon RS
Minerva Cardioangiol; 2002 Aug; 50(4):273-90. PubMed ID: 12147959
[TBL] [Abstract][Full Text] [Related]
16. Implantable defibrillators and sudden cardiac death.
Josephson M; Wellens HJ
Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
[No Abstract] [Full Text] [Related]
17. Randomized clinical trials: how long should they last?
Wellens HJ
Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
[No Abstract] [Full Text] [Related]
18. Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce: how much will we pay to save a life?
Zipes DP
Circulation; 2001 Mar; 103(10):1372-4. PubMed ID: 11245637
[No Abstract] [Full Text] [Related]
19. [Guidelines for cardioverter defibrillator implantation].
Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
[No Abstract] [Full Text] [Related]
20. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
